Early assessment of tumor response to JAC106, an anti-tubulin agent, by 3'-deoxy-3'-[¹?F]fluorothymidine in preclinical tumor models.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples